Imugene HER-Vaxx AACR 2021 Poster: Dr Rita Laeufle oral presentation

(5:2)

Imugene Officially Announce Their HER-Vaxx Trial Results

(8:59)

Imugene HER-Vaxx video ASX: IMU | AN EMERGING LEADER IN CANCER IMMUNO-ONCOLOGY

(4:49)

Imugene CEO hails clinical milestone for HER-Vaxx cancer immunotherapy

(6:15)

Imugene thrilled with ethics approval for phase 2 HER-Vaxx trial

(4:45)

Imugene's HER-Vaxx Immunotherapy Treatment: Explained

(3:15)

Imugene releases final data from Phase 2 HER Vaxx study

(5:30)

Imugene will present lead candidate HER-Vaxx at AACR Annual Meeting

(2:16)

THRONE OF UMUNGENE KINGDOM SEASON 1\u00262 FULL MOVIE - UGEZU J UGEZU 2021 LATEST NOLLYWOOD MOVIE

(5:40:23)

How I found out I had Gastric Cancer/Symptoms

(30:15)

Stomach Cancer Survivor Story, Gene Mutation | Lauren Chaisson | The Patient Story

(1:13:48)

NASTEEXO INDHO | WAR HADAADAN TUMEYN | \

(6:51)

Paul Hopper – ASX Biotech: Understanding The Biotech Space With A Leading ASX Chairman/Entrepreneur

(26:30)

Infinity Series with Imugene Chairman Paul Hopper ASX: IMU

(29:41)

Imugene + Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus.

(29:19)

Uroosa Khalid: Stage 4 Stomach Cancer at 27 Years Old

(6:3)

Killing Cancer with Viruses? By Professor Yuman Fong, Inventor of Oncolytic Virus CF33

(20:44)

Imugene (ASX: IMU) – New Global Partnership Announced For This Leading ASX Biotech

(14:2)

Imugene: Serious inroads – a highly successful cancer drug trial

(3:7)

Imugene (ASX: IMU) – The ‘Holy Grail’ Of Cancer Treatment…?! | ASX CEO Interview 🚀📈

(20:37)

Imugene Ltd (ASX:IMU) Investor Presentation 2017

(13:15)

Imugene Investor Webinar: MAST Study Update

(27:13)

Imugene bringing effective new treatments and options to cancer patients

(11:25)

Imugene welcomes dosing of first patient in nextHERIZON Phase 2 clinical trial

(5:20)

Imugene forges development path of immunotherapies and cancer-killing virus

(24:2)

How Imugene is Turning Viruses into Cancer-Fighting Heroes!

(32:27)

Breakthrough therapy entering clinical trials. Cancer killing virus by Imugene is sheer genius!!

(13:40)

ASX CEO Connect March 2023 Imugene Limited (ASX: IMU)

(18:10)

Imugene delighted as first cohort 3 patient dosed in CHECKvacc trial

(4:45)